Latest Retail News

RLF AgTech has appointed Stuart Upton as CEO, marking a strategic shift towards disciplined execution and commercial scaling of its crop nutrition and carbon platforms. Former Acting Managing Director Gavin Ball returns to Executive Director to focus on international expansion.

Region Group has reported a robust first half for FY26, with solid growth in funds from operations and an upgraded earnings outlook. Strategic acquisitions and portfolio management underpin its positive momentum.

Dexus Convenience Retail REIT has reported solid half-year results for 2026, underpinned by resilient income growth and a $19.8 million uplift in portfolio valuation. The fund maintains a conservative capital structure while advancing key development projects.

PYC Therapeutics has initiated a substantial capital raising effort, aiming to secure up to A$653 million to propel its four RNA therapeutic candidates through critical clinical milestones. The retail entitlement offer opens today, following a successful institutional placement.

Dexus Convenience Retail REIT (DXC) reports solid HY26 results with strong income growth and high occupancy, while advancing strategic development projects to enhance its metro and highway retail footprint.

Scentre Group has announced an ordinary dividend of AUD 0.08905 per security for the six months ending December 2025, with a Dividend Reinvestment Plan option available. The full year results will be released on 24 February 2026.

Dexus Convenience Retail REIT has reported a striking 143.8% increase in net profit for the half-year to December 2025, underpinned by strong portfolio occupancy and rising property valuations. The REIT reaffirmed its FY26 guidance, signalling confidence in its defensive income strategy and development pipeline.

CAR Group Limited has announced a fully paid ordinary dividend of AUD 0.425 per share for the six months ending December 2025, accompanied by a Dividend Reinvestment Plan (DRP) with no discount.

Kalamazoo Resources has successfully closed an oversubscribed Share Purchase Plan, raising $4.1 million to fast-track drilling and development at its Ashburton Gold Project. Combined with a recent placement, the company secures $12.1 million to advance exploration and pre-feasibility studies.

Charter Hall Retail REIT reported a robust half-year result with statutory profit surging to $240.7 million, driven by portfolio growth and strategic transactions. The REIT also advanced its convenience retail focus and announced a major debt refinancing.

Cyclopharm Limited is accelerating its US market push for Technegas with a A$16 million capital raise following a record 2025 sales performance. The company aims to expand its US installations and advance new clinical applications beyond pulmonary embolism.

PYC Therapeutics has successfully closed a $537 million institutional placement and entitlement offer, positioning the company to raise at least $600 million to advance its RNA-based therapies targeting genetic diseases.